We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
-4.25%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.1M
AUM Growth
-$39.1M
Cap. Flow
-$42.6M
Cap. Flow %
-48.9%
Top 10 Hldgs %
44.48%
Holding
450
New
86
Increased
61
Reduced
79
Closed
202

Top Buys

1
STZ icon
Constellation Brands
STZ
+$3.18M
2
JPM icon
JPMorgan Chase
JPM
+$3.16M
3
GIS icon
General Mills
GIS
+$2.29M
4
GILD icon
Gilead Sciences
GILD
+$2.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Top Sells

1
PG icon
Procter & Gamble
PG
+$4.04M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.96M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$2.56M
4
IBB icon
iShares Biotechnology ETF
IBB
+$2.03M
5
HUM icon
Humana
HUM
+$1.77M

Sector Composition

1 Healthcare 44.7%
2 Consumer Staples 14.06%
3 Consumer Discretionary 4.38%
4 Financials 4.11%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
401
DELISTED
Splunk Inc
SPLK
– –
-7,940
Closed -$466K
SPLK
402
PUT
DELISTED
Splunk Inc
SPLK
– –
-18,100
Closed -$57K
ISEE
403
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$0 ﹤0.01%
26
-3,608
-99% -$107K
NYMX
404
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
– –
-10,000
Closed -$26K
ACOR
405
PUT
DELISTED
Acorda Therapeutics
ACOR
– –
-183
Closed -$92K
CLVS
406
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-54,400
Closed -$212K
CLVS
407
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-71,091
Closed -$2.56M
CLVS
408
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-72,800
Closed -$42K
AERI
409
CALL
DELISTED
Aerie Pharmaceuticals
AERI
– –
-14,900
Closed -$177K
AERI
410
DELISTED
Aerie Pharmaceuticals
AERI
– –
-16,630
Closed -$628K
TWTR
411
CALL
DELISTED
Twitter, Inc.
TWTR
– –
-80,000
Closed -$122K
TWTR
412
PUT
DELISTED
Twitter, Inc.
TWTR
– –
-30,000
Closed -$68K
MNDT
413
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-13,000
Closed -$7K
MNDT
414
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-1,293
Closed -$19K
ENDP
415
CALL
DELISTED
Endo International plc
ENDP
– –
-10,000
Closed -$14K
ENDP
416
DELISTED
Endo International plc
ENDP
– –
-6,800
Closed -$137K
ENDP
417
PUT
DELISTED
Endo International plc
ENDP
– –
-15,000
Closed -$4K
CSOD
418
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
– –
-40,200
Closed -$120K
AGN
419
CALL
DELISTED
Allergan plc
AGN
– –
-10,800
Closed -$21K
AGN
420
DELISTED
Allergan plc
AGN
– –
-3,316
Closed -$764K
AGN
421
PUT
DELISTED
Allergan plc
AGN
– –
-6,000
Closed -$149K
SFLY
422
CALL
DELISTED
Shutterfly, Inc.
SFLY
– –
-15,000
Closed -$17K
SFLY
423
DELISTED
Shutterfly, Inc.
SFLY
– –
-2,500
Closed -$112K
DATA
424
CALL
DELISTED
Tableau Software, Inc.
DATA
– –
-24,800
Closed -$41K
INSY
425
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-20,000
Closed -$18K
14 15 16
17
18

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2016 Portfolio in Review

As of Q4 2016, FT Options held 450 positions worth $87.1M, down 31% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $42.6M in Q4 2016, closing 202 positions and reducing 79 holdings. Its most notable exit was Procter & Gamble, an estimated $4.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 40% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Constellation Brands worth $3.07M.

  • FT Options's largest Q4 2016 buy was Constellation Brands: 20,000 shares worth $3.07M.
  • FT Options added most to General Mills in Q4 2016, an estimated $2.29M increase.
  • FT Options's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $1.06M.
  • FT Options fully exited Procter & Gamble in Q4 2016, selling an estimated $4.04M.
  • FT Options's ten largest holdings make up 44% of its $87.1M portfolio in Q4 2016.
  • FT Options opened 86 new positions and closed 202 in Q4 2016.
  • FT Options's portfolio value fell 31% quarter-over-quarter to $87.1M.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.